|Articles|July 9, 2019
Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster
Advertisement
Symbio LLC has announced the signing of a five-year contract with OmniComm Systems, Inc., to use their TrialMaster version 5 to develop and manage clinical study databases.
For more information, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
4
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
5